Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Time-of-Flight PET/CT Imaging of Ga-68-Dotatate: Normal Pattern, SUV Quantification, and Differences from Non-Time-of-Flight Imaging.
Journal: World journal of nuclear medicine
Published: June 27, 2024
Prospective Evaluation of 18F-DCFPyL PET/CT in Detection of High-Risk Localized Prostate Cancer: Comparison With mpMRI.
Journal: AJR. American journal of roentgenology
Published: August 07, 2020
18F-DCFPyL PET/CT Imaging in Patients with Biochemically Recurrent Prostate Cancer After Primary Local Therapy.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: August 06, 2019
18F-Sodium fluoride PET/CT predicts overall survival in patients with advanced genitourinary malignancies treated with cabozantinib and nivolumab with or without ipilimumab.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 16, 2019
Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-5-Fluoro-2'-Deoxycytidine with Tetrahydrouridine in Solid Tumors.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: July 05, 2018
A Prospective Comparison of 18F-Sodium Fluoride PET/CT and PSMA-Targeted 18F-DCFBC PET/CT in Metastatic Prostate Cancer.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: December 21, 2017
Positron emission tomography (PET) in primary prostate cancer staging and risk assessment.
Journal: Translational andrology and urology
Published: July 21, 2017
Clinical impact of PSMA-based 18F-DCFBC PET/CT imaging in patients with biochemically recurrent prostate cancer after primary local therapy.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 16, 2017
Imaging Locally Advanced, Recurrent, and Metastatic Prostate Cancer: A Review.
Journal: JAMA oncology
Published: January 18, 2017
Utility of 18F-fluoroestradiol (18F-FES) PET/CT imaging as a pharmacodynamic marker in patients with refractory estrogen receptor-positive solid tumors receiving Z-endoxifen therapy.
Journal: European journal of nuclear medicine and molecular imaging
Published: June 22, 2016
ANG1005 for breast cancer brain metastases: correlation between 18F-FLT-PET after first cycle and MRI in response assessment.
Journal: Breast cancer research and treatment
Published: June 20, 2016
Last Updated: 09/26/2026